Perry Sternberg
Patrimonio netto: - $ in data 31/08/2026
Patrimonio netto: - $ in data 31/08/2026
Perry J.
Sternberg is currently Chief Executive Officer & Director at Sydnexis, Inc. since 2024, Lead Independent Director at Harrow, Inc. since 2022, and Director at Surface Ophthalmics, Inc. Former positions include President & Chief Executive Officer at Corium LLC (Massachusetts) from 2019 to 2024, Chief Executive Officer at Corium Innovations, Inc., President, Chief Executive Officer & Director at Corium LLC, Head-Neuroscience Business Unit at Shire Plc from 2013 to 2019, and Vice President & General Manager at Bausch & Lomb, Inc. Education includes an undergraduate degree from The Pennsylvania State University, conferred in 1990.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
HARROW, INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HARROW, INC. | Direttore/Membro del Consiglio | 31/03/2022 |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Direttore/Membro del Consiglio | - |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | 01/08/2024 |
| Società | Posizione | Fine |
|---|---|---|
| CORIUM INTERNATIONAL INC | Amministratore Delegato | 01/07/2024 |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Amministratore Delegato | 17/01/2023 |
| SHIRE | Corporate Officer/Principal | 01/01/2019 |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Corporate Officer/Principal | - |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Harrow, Inc.
Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Health Technology |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Health Technology |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale